Overview

Lidocaine for Pain After Urodynamic Testing

Status:
Completed
Trial end date:
2019-03-29
Target enrollment:
0
Participant gender:
Female
Summary
Urodynamic testing can be associated with mild discomfort, particularly at the time of insertion, repositioning, and removal of the bladder catheter (a tube inserted into the bladder via the urethra). Few studies have investigated ways to improve patient comfort during this procedure. In this study, the investigators want to see if applying external lidocaine (a numbing gel) prior to the procedure can help to minimize patient discomfort.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Atlantic Health System
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

• All female patients between the ages of 40-80 undergoing urodynamic testing.

Exclusion Criteria:

- Urinary tract infection or symptoms of infection at time of procedure or within past 2
weeks

- History of urinary retention

- Known or suggested history of urethral syndrome or painful bladder syndrome

- Prior anti-incontinence surgery

- Prior pelvic surgery with placement of transvaginal mesh

- Known urethral or bladder anomaly including urethral diverticulum or congenital
anomalies of the bladder or urethra

- History of genital herpes outbreak within the past 3 months

- Defects in mucosal surfaces including periurethral or vaginal abrasions, ulcerations,
or lacerations

- Neurologic disease affecting urethral sensation

- Chronic pelvic pain

- Contraindication or allergy to topical anesthetic

- Pregnancy

- Syncopal episode during preparation for or execution of uroflowometry